April 24, 2020 / 8:46 AM / a month ago

BRIEF-Tasly Pharmaceutical's 2019 Net Profit Down, Plans To Issue Commercial Paper And Medium-term Notes

April 24 (Reuters) - Tasly Pharmaceutical Group Co Ltd :

* SAYS 2019 NET PROFIT DOWN 35.2% Y/Y AT 1.0 BILLION YUAN ($141.25 million)

* SAYS Q1 NET PROFIT DOWN 34.2% Y/Y AT 294.9 MILLION YUAN

* SAYS IT PLANS TO ISSUE COMMERCIAL PAPER, MEDIUM-TERM NOTES WORTH UP TO 2.0 BILLION YUAN EACH Source text in Chinese: bit.ly/2VyvGR5; bit.ly/3bxYJty; bit.ly/2S2JW2s; bit.ly/2xSP3v2 Further company coverage: ($1 = 7.0796 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below